1-11 of 11
Peter W. M. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Smart salvage treatment for Hodgkin lymphoma

Clinical Trials & Observations
Peter W. M. Johnson
Journal: Blood
Blood (2022) 139 (25): 3563–3564.
https://doi.org/10.1182/blood.2022016274
Published: 2022
Journal Articles

Optimizing therapy in advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Sean H. Lim, Peter W. M. Johnson
Journal: Blood
Blood (2018) 131 (15): 1679–1688.
https://doi.org/10.1182/blood-2017-09-772640
Published: 2018
Journal Articles

A Prospective Randomised Trial of Targeted Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) Based upon Real-Time Gene Expression Profiling: The Remodl-B Study of the UK NCRI and SAKK Lymphoma Groups (ISRCTN51837425)

Andrew J Davies, MRCP PhD, Josh Caddy, Tom Maishman, Sharon Barrans, PhD, Christoph Mamot, MD, Matthew Care, PhD, Christopher Pocock, Louise Stanton, PhD, Debbie Hamid, Keith Pugh, PhD, Andrew McMillan, PhD, Paul Fields, MDPhD, Anton Kruger, Andrew Jack, PhD MB, Peter W. M. Johnson, FRCP
Journal: Blood
Blood (2015) 126 (23): 812.
https://doi.org/10.1182/blood.V126.23.812.812
Published: 2015
Journal Articles

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Clinical Trials & Observations
Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J. M. Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini, Francesco Merli, Graziella Pinotti, Donato Mannina, Stefano Luminari, Anastasios Stathis, Eleonora Russo, Franco Cavalli, Luca Giovanella, Peter W. M. Johnson, Emanuele Zucca
Journal: Blood
Blood (2015) 126 (8): 950–956.
https://doi.org/10.1182/blood-2014-12-616474
Published: 2015
Includes: Supplemental data
Journal Articles

The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model

Matthew D. Blunt, Matthew J. Carter, Marta Larrayoz, Lindsay D. Smith, Maria Aguilar-Hernandez, Kerry L. Cox, Thomas Tipton, Mark Reynolds, Sarah Murphy, Elizabeth Lemm, Samantha Dias, Andrew Duncombe, Jonathan C. Strefford, Peter W. M. Johnson, Francesco Forconi, Freda K. Stevenson, Graham Packham, Mark S. Cragg, Andrew J. Steele
Journal: Blood
Blood (2015) 125 (26): 4032–4041.
https://doi.org/10.1182/blood-2014-11-610329
Published: 2015
Includes: Supplemental data
Journal Articles

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy

Sean H. Lim, Andrew T. Vaughan, Margaret Ashton-Key, Emily L. Williams, Sandra V. Dixon, H. T. Claude Chan, Stephen A. Beers, Ruth R. French, Kerry L. Cox, Andrew J. Davies, Kathleen N. Potter, C. Ian Mockridge, David G. Oscier, Peter W. M. Johnson, Mark S. Cragg, Martin J. Glennie
Journal: Blood
Blood (2011) 118 (9): 2530–2540.
https://doi.org/10.1182/blood-2011-01-330357
Published: 2011
Includes: Supplemental data
Journal Articles

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

Stephen A. Beers, Ruth R. French, H. T. Claude Chan, Sean H. Lim, Timothy C. Jarrett, Regina Mora Vidal, Sahan S. Wijayaweera, Sandra V. Dixon, Hyungjin Kim, Kerry L. Cox, Jonathan P. Kerr, David A. Johnston, Peter W. M. Johnson, J. Sjef Verbeek, Martin J. Glennie, Mark S. Cragg
Journal: Blood
Blood (2010) 115 (25): 5191–5201.
https://doi.org/10.1182/blood-2010-01-263533
Published: 2010
Includes: Supplemental data
Journal Articles

Phase 1/2 study of fractionated 131 I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy

Clinical Trials & Observations
Tim M. Illidge, Mike Bayne, Nicholas S. Brown, Samantha Chilton, Mark S. Cragg, Martin J. Glennie, Yong Du, Valerie Lewington, James Smart, James Thom, Maureen Zivanovic, Peter W. M. Johnson
Journal: Blood
Blood (2009) 113 (7): 1412–1421.
https://doi.org/10.1182/blood-2008-08-175653
Published: 2009
Journal Articles

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy

Yong Du, Jamie Honeychurch, Mark S. Cragg, Mike Bayne, Martin J. Glennie, Peter W. M. Johnson, Tim M. Illidge
Journal: Blood
Blood (2004) 103 (4): 1485–1494.
https://doi.org/10.1182/blood-2003-06-2037
Published: 2004
Journal Articles

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell–dependent immunity to B-cell lymphoma

Jamie Honeychurch, Martin J. Glennie, Peter W. M. Johnson, Timothy M. Illidge
Journal: Blood
Blood (2003) 102 (4): 1449–1457.
https://doi.org/10.1182/blood-2002-12-3717
Published: 2003
Journal Articles

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

Mark S. Cragg, Suzanne M. Morgan, H. T. Claude Chan, B. Paul Morgan, A. V. Filatov, Peter W. M. Johnson, Ruth R. French, Martin J. Glennie
Journal: Blood
Blood (2003) 101 (3): 1045–1052.
https://doi.org/10.1182/blood-2002-06-1761
Published: 2003